Expression and clinical prognostic value of m6A RNA methylation modification in breast cancer

Biomarker Research

Table 1 Clinicopathological features of breast cancer patients from different databases (n)

Parameters	Total	TCGA	METABRIC	Clinical cohort
Age	<=60	601	876	81
Age	> 60	490	1109	53
localization	Left breast	567	973	58
	Right breast	523	897	71
	others	1	115	5
T	T1	280	854	33
	T2	631	1004	84
	T3	137	94	11
	T4	40	7	2
	others	3	26	4
N	N0	535	1037	67
	N1	360	624	36
	N2	120	226	18
	N3	76	91	13
	Others	NS	7	NS
pTNM stage	I	182	552	19
	II	622	1094	75
	III	249	312	36
	Others	38	22	4
HER2 status	HER2 positive	182	247	42
HER2 status	HER2 negative	753	1733	92
PAM50 molecular typing	Basal	171	329	NS
	Her2	78	240	NS
	Luminal A	497	720	NS
	Luminal B	196	490	NS
	Normal	36	200	NS
	Others	113	6	NS
All patients	total number	1091	1985	134

NS not shown, TCGA The Cancer Genome Atlas, METABRIC Molecular Taxonomy of Breast Cancer International Consortium. Databases including: TCGA cohort, METABRIC database, and one Clinical database. K-M plotter website database is not listed here (from the website: https://kmplot.com/analysis/)

ISSN: 2050-7771